(XOMA)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

XOMA Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-01-05 BVF PARTNERS L P/IL director 1,788,168 P-Purchase A 3,330 18.39 61,222.72
2023-01-06 BVF PARTNERS L P/IL director 1,789,844 P-Purchase A 1,676 21.98 36,841.33
2023-01-05 BVF PARTNERS L P/IL director 1,617,064 P-Purchase A 15,670 18.39 288,096.08
2023-01-06 BVF PARTNERS L P/IL director 1,618,637 P-Purchase A 1,573 21.98 34,577.21
2023-01-01 Hughes Owen None 0 None None 0.00
2023-01-03 Sitko Bradley director: Chief Investment Officer 300,000 A-Award A 300,000 0.00 0.00
2023-01-03 Sitko Bradley director: Chief Investment Officer 250,000 A-Award A 250,000 0.00 0.00
2023-01-03 Hughes Owen director: Interim CEO 100,000 A-Award A 100,000 0.00 0.00
2023-01-03 Hughes Owen director: Interim CEO 75,000 A-Award A 75,000 0.00 0.00
2023-01-03 Sitko Bradley None 0 None None 0.00
2022-11-08 BURNS THOMAS M. director: SVP, Finance & CFO 11,000 A-Award A 11,000 0.00 0.00
2022-07-15 BURNS THOMAS M. director: SVP, Finance & CFO 6,555 S-Sale D 2,000 31.66 63,321.00
2022-07-15 BURNS THOMAS M. director: SVP, Finance & CFO 75,778 M-Exempt D 2,000 0.00 0.00
2022-07-15 Neal James R director: CEO 15,939 S-Sale D 20,883 29.55 617,094.74
2022-07-15 Neal James R director: CEO 218,056 M-Exempt D 25,000 0.00 0.00
2022-05-18 LAMPERT MARK N director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 PERRY MATTHEW D director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 LIMBER JOSEPH M director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 WYSZOMIERSKI JACK L director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 Hernday Natasha director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 VAN NESS W DENMAN director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 Kosacz Barbara director: 8,996 A-Award A 8,996 0.00 0.00
2022-05-18 Franklin Heather L director: 8,996 A-Award A 8,996 0.00 0.00
2022-03-21 Neal James R director: CEO 102,800 M-Exempt D 1,111 0.00 0.00
2022-03-21 Neal James R director: CEO 11,822 S-Sale D 2,339 30.02 70,208.59
2022-03-21 BURNS THOMAS M. director: SVP, Finance & CFO 6,555 S-Sale D 2,339 30.02 70,208.59
2022-03-21 BURNS THOMAS M. director: SVP, Finance & CFO 18,000 M-Exempt D 12,000 0.00 0.00
2020-05-20 WYSZOMIERSKI JACK L director 6,152 A-Award A 6,152 21.27 130,853.04
2020-03-13 BVF PARTNERS L P/IL director 1,247,676 P-Purchase A 100,000 18.34 1,834,090.00
2020-03-16 BVF PARTNERS L P/IL director 1,257,840 P-Purchase A 10,164 15.73 159,916.31
2020-03-17 BVF PARTNERS L P/IL director 1,265,953 P-Purchase A 8,113 15.73 127,647.51
2018-11-15 VAN NESS W DENMAN director 11,646 M-Exempt A 4,667 4.03 18,808.01
2018-11-15 VAN NESS W DENMAN director 14,672 M-Exempt A 3,026 11.20 33,891.20
2018-11-15 VAN NESS W DENMAN director 9,144 S-Sale D 5,528 12.67 70,039.76
2018-11-15 VAN NESS W DENMAN director 3,333 M-Exempt D 4,667 4.03 18,808.01
2018-11-15 VAN NESS W DENMAN director 0 M-Exempt D 3,026 11.20 33,891.20
2017-02-10 HUTT PETER BARTON director 8,000 A-Award A 8,000 4.03 32,240.00
2017-03-02 PERRY MATTHEW D director 11,799 A-Award A 11,799 0.00 0.00
2017-03-02 PERRY MATTHEW D director 15,222 A-Award A 15,222 4.67 71,086.74
2016-05-28 WYSZOMIERSKI JACK L director 81,068 M-Exempt A 2,800 0.00 0.00
2016-05-28 WYSZOMIERSKI JACK L director 0 M-Exempt D 2,800 0.00 0.00
2016-05-28 Walbert Timothy P director 81,068 M-Exempt A 2,800 0.00 0.00
2016-05-28 Walbert Timothy P director 0 M-Exempt D 2,800 0.00 0.00
2016-03-22 Neal James R officer: VP Business Development 411,339 S-Sale D 19,813 0.78 15,547.26
2015-05-15 Varian John director, officer: CEO 562,414 M-Exempt A 10,000 1.24 12,400.00
2015-05-15 Varian John director, officer: CEO 552,414 S-Sale D 10,000 3.34 33,400.00
2015-05-15 Varian John director, officer: CEO 90,392 M-Exempt D 10,000 1.24 12,400.00
2015-03-23 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 119,467 S-Sale D 32,742 3.94 128,879.06
2015-02-26 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 142,398 A-Award A 64,900 0.00 0.00
2015-02-26 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 86,910 A-Award A 86,910 3.83 332,865.30
2014-12-31 SCANNON PATRICK J MD PHD officer: Exec. VP & CSO 25,080 I 0 3.83 0.00
2014-11-20 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 77,021 M-Exempt A 5,000 3.04 15,200.00
2014-11-20 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 72,021 S-Sale D 5,000 4.55 22,750.00
2014-11-20 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 72,040 M-Exempt D 5,000 3.04 15,200.00
2014-10-28 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 77,021 M-Exempt A 5,000 3.04 15,200.00
2014-10-28 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 72,021 S-Sale D 5,000 4.57 22,829.00
2014-10-28 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 72,040 M-Exempt D 5,000 3.04 15,200.00
2014-09-12 BAKER BROS. ADVISORS LP director 2,843,653 A-Award A 5,500 0.00 0.00
2014-09-12 BAKER BROS. ADVISORS LP director 19,781,670 A-Award A 5,500 0.00 0.00
2014-09-12 BAKER BROS. ADVISORS LP director 524,349 A-Award A 5,500 0.00 0.00
2014-09-12 BAKER BROS. ADVISORS LP director 7,000 A-Award A 7,000 4.73 33,110.00
2014-09-12 BOWES WILLIAM K JR director 32,368 A-Award A 5,500 0.00 0.00
2014-09-12 BOWES WILLIAM K JR director 7,000 A-Award A 7,000 4.73 33,110.00
2014-02-27 SCANNON PATRICK J MD PHD officer: Exec. VP & CSO 85,465 A-Award A 43,448 0.00 0.00
2014-02-27 SCANNON PATRICK J MD PHD officer: Exec. VP & CSO 60,000 A-Award A 60,000 8.91 534,600.00
2013-11-16 Neal James R officer: VP Business Development 0 D 37,296 10.73 399,999.60
2013-10-27 Neal James R officer: VP Business Development 0 D 9,758 1.69 16,491.02
2013-12-01 Neal James R officer: VP Business Development 0 D 15,625 7.35 114,843.75
2013-11-16 Neal James R officer: VP Business Development 0 D 16,037 10.73 171,996.82
2014-01-21 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 3,228 S-Sale D 5,694 8.27 47,077.99
2014-01-21 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 8,922 M-Exempt A 5,694 3.04 17,309.76
2014-01-21 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 104,040 M-Exempt D 5,694 3.04 17,309.76
2013-06-11 SCANNON PATRICK J MD PHD officer: Exec. VP & CSO 27,448 M-Exempt A 10,000 1.69 16,900.00
2013-06-11 SCANNON PATRICK J MD PHD officer: Exec. VP & CSO 17,448 S-Sale D 10,000 4.00 40,000.00
2013-06-11 SCANNON PATRICK J MD PHD officer: Exec. VP & CSO 13,274 M-Exempt D 10,000 4.00 40,000.00
2013-05-28 Walbert Timothy P director 7,299 M-Exempt A 2,800 0.00 0.00
2013-05-28 Walbert Timothy P director 5,600 M-Exempt D 2,800 0.00 0.00
2012-12-31 RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO 4,422 I 0 2.53 0.00
2012-11-13 Varian John officer: Director and CEO 4,499 M-Exempt A 4,499 0.00 0.00
2012-11-13 Varian John officer: Director and CEO 100,666 M-Exempt A 96,167 0.00 0.00
2012-11-14 Varian John officer: Director and CEO 98,852 S-Sale D 1,814 2.56 4,640.94
2012-11-14 Varian John officer: Director and CEO 60,079 S-Sale D 38,773 2.56 99,165.82
2012-11-13 Varian John officer: Director and CEO 297,496 M-Exempt D 4,499 0.00 0.00
2012-11-13 Varian John officer: Director and CEO 201,329 M-Exempt D 96,167 0.00 0.00
2012-10-29 BAKER JULIAN director 1,922,230 P-Purchase A 336,639 3.00 1,009,917.00
2012-10-29 BAKER JULIAN director 17,888,512 P-Purchase A 4,282,419 3.00 12,847,257.00
2012-10-29 BAKER JULIAN director 463,839 P-Purchase A 103,608 3.00 310,824.00
2012-07-19 Varian John officer: Director and CEO 391,805 A-Award A 391,805 3.53 1,383,071.65
2012-07-19 Varian John officer: Director and CEO 283,721 A-Award A 283,721 0.00 0.00
2012-07-19 SCANNON PATRICK J MD PHD officer: Executive Vice President 67,381 A-Award A 67,381 3.53 237,854.93
2012-07-19 SCANNON PATRICK J MD PHD officer: Executive Vice President 48,793 A-Award A 48,793 0.00 0.00
2012-05-24 VAN NESS W DENMAN director 13,050 A-Award A 13,050 2.36 30,798.00
2012-05-24 VAN NESS W DENMAN director 9,450 A-Award A 9,450 0.00 0.00
2012-02-10 RUBIN PAUL D officer: VP Clinical Dev. & CMO 54,615 A-Award A 54,615 0.00 0.00
2011-12-30 MARGOLIN CHRISTOPHER J officer: VP, General Counsel & Sec'y 15,853 I 0 1.16 0.00
2011-10-27 WYSZOMIERSKI JACK L director 17,544 A-Award A 17,544 1.69 29,649.36
2011-10-27 WYSZOMIERSKI JACK L director 13,495 A-Award A 13,495 0.00 0.00
2011-10-27 MARGOLIN CHRISTOPHER J officer: VP, General Counsel & Sec'y 37,642 A-Award A 37,642 1.69 63,614.98
2011-10-27 MARGOLIN CHRISTOPHER J officer: VP, General Counsel & Sec'y 51,248 A-Award A 51,248 1.69 86,609.12
2011-10-27 MARGOLIN CHRISTOPHER J officer: VP, General Counsel & Sec'y 68,377 A-Award A 68,377 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.